-
1دورية أكاديمية
المؤلفون: Flora Peyvandi, Syna Miri, Isabella Garagiola
المصدر: Frontiers in Immunology, Vol 11 (2021)
مصطلحات موضوعية: recombinant products, plasma-derived products, inhibitors, von Willebrand factor, post-translational modification, cell lines, Immunologic diseases. Allergy, RC581-607
وصف الملف: electronic resource
-
2
المؤلفون: Roberta Palla, Syna Miri, Carla Valsecchi, Frits R. Rosendaal, Paolo Bucciarelli, Marco Boscarino, Lucia Schiavone, Pier Mannuccio Mannucci, Flora Peyvandi
المصدر: British Journal of Haematology. WILEY
British Journal of Haematologyمصطلحات موضوعية: Male, medicine.medical_specialty, Haemophilia A, haemophilia A, Hemophilia A, Gastroenterology, Subclass, Persistence (computer science), predictive biomarkers, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Humans, Medicine, IgG subclasses, Predictive biomarker, Factor VIII, business.industry, Infant, Hematology, Igg subclasses, medicine.disease, inhibitor, Child, Preschool, Immunoglobulin G, 030220 oncology & carcinogenesis, Concomitant, Female, Severe haemophilia A, business, Biomarkers, 030215 immunology
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c21e193dfa40f2917eaa570a5761389
https://hdl.handle.net/1887/3277322 -
3
المؤلفون: Flora Peyvandi, Syna Miri, Isabella Garagiola
المصدر: Frontiers in Immunology
Frontiers in Immunology, Vol 11 (2021)مصطلحات موضوعية: lcsh:Immunologic diseases. Allergy, congenital, hereditary, and neonatal diseases and abnormalities, Side effect, Immunology, Review, cell lines, 030204 cardiovascular system & hematology, Pharmacology, von Willebrand factor, Hemophilia A, law.invention, 03 medical and health sciences, 0302 clinical medicine, Immune system, Von Willebrand factor, law, Isoantibodies, hemic and lymphatic diseases, inhibitors, Immunology and Allergy, Medicine, Animals, Humans, Neutralizing antibody, Emicizumab, Factor VIII, biology, Blood Coagulation Factor Inhibitors, business.industry, plasma-derived products, Immunogenicity, Incidence, Antibodies, Neutralizing, Blood Coagulation Factors, Recombinant Proteins, post-translational modification, recombinant products, biology.protein, Recombinant DNA, Antibody, lcsh:RC581-607, business, 030215 immunology
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bb98289224fc9cb20135a33319be45a
https://pubmed.ncbi.nlm.nih.gov/33552050